Home
Conditions
Uterine Neoplasms

Clinical trial condition

Uterine Neoplasms

Explore clinical trials studying Uterine Neoplasms. Study availability and eligibility vary by location and protocol.

2,258 public trials 566 recruiting studies

Refine in advanced search Browse all conditions

Uterine Neoplasms trial results

Enrolling by Invitation

Establishment and Validation of Prediction Model of Simultaneous Chemoradiotherapy for Cervical Cancer Organoids

NCT06786780

Conditions: Cervical Cancer Treated with Pelvic Radiotherapy, Cervical Cancers, Female Urogenital Diseases, +12 more
Locations: Chongqing university Cancer Hospital Chongqing, China

View Trial Details

Enrolling by Invitation

The Use of the LuViva Advanced Cervical Scan to Identify Women at High-Risk for Cervical Neoplasia

NCT04915495

Conditions: Cervical Dysplasia, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations: University of Alabama Birmingham- Heersink School of Medicine Birmingham, Alabama, United States

Emory University- Winship Cancer Institute Atlanta, Georgia, United States

Great Lakes Bay Health Centers Bay City, Michigan, United States

Tidewater Clinical Research Norfolk, Virginia, United States

View Trial Details

Enrolling by Invitation

Clinical Triage and Treatment of Atypical Glandular Cells (AGC) Detected in Screening

NCT05231993

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, +11 more
Locations: Karolinska University Hospital Stockholm, Sweden

View Trial Details

Enrolling by Invitation

Evaluation of AK104 (Cadonilimab) Combined with Chemotherapy for Recurrent or Metastatic Small Cell Neuroendocrine Carcinoma of the Cervix

NCT06810895

Conditions: Cadonilimab, Cervix Cancer, Female Urogenital Diseases, +13 more
Locations: ongji Hospital, Tongji Medical College, Huazhong University of Science andTechnology Wuhan, China

View Trial Details

Enrolling by Invitation

A Phase Ⅱ/Ⅲ Study of Rulonilimab Plus Chemotherapy± Bevacizumab for the First-Line Treatment of Persistent, Recurrent or Metastatic Cervical Cancer

NCT06755515

Conditions: Cervical Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +11 more
Locations: Shandong New Time Pharmaceutical Co., LTD Linyi, Shandong, China

View Trial Details

Enrolling by Invitation

Accelerating the Implementation of a Breast and Cervical Cancer Screening and HPV Vaccination Intervention

NCT05524480

Conditions: Breast Diseases, Breast Neoplasms, Cancer Prevention, +15 more
Locations: The University of Texas Health Science Center at Houston Houston, Texas, United States

View Trial Details

Enrolling by Invitation

CNCMT：a Multi-center, Prospective, Single-arm Study

NCT06714084

Conditions: CTLA4, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations: Hubei Cancer Hospital Wuhan, Hubei, China

View Trial Details

Enrolling by Invitation

HPV Self-sampling to Improve Access to Cervical Cancer Screening for Persons With HIV and/or Underserved Individuals

NCT05528237

Conditions: Cervical Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +11 more
Locations: SHE Clinic Seattle, Washington, United States

Madison Clinic Seattle, Washington, United States

MAX Clinic Seattle, Washington, United States

View Trial Details

Not Yet Recruiting

A Blended e-Health Intervention to Improve Fear of Progression in Women With Gynecologic or Breast Cancer

NCT07741968

Conditions: Adnexal Diseases, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, +44 more
Locations: City of Hope Medical Center Duarte, California, United States

City of Hope at Irvine Lennar Irvine, California, United States

View Trial Details

Not Yet Recruiting

Elemene Liposomes in Endometrial Cancer

NCT07738315

Conditions: Endometrial Carcinoma, Endometrial Neoplasms, Female Urogenital Diseases, +10 more
Locations: Women's hospital School of Medicine Zhejiang University Hangzhou, Zhejiang, China

View Trial Details

Uterine Neoplasms

Uterine Neoplasms trial results

Related conditions